Jayda Rupp, APRN

NPI: 1063892677
Total Payments
$5,464
2024 Payments
$1,326
Companies
31
Transactions
323
Medicare Patients
1,231
Medicare Billing
$85,649

Payment Breakdown by Category

Food & Beverage$5,389 (98.6%)
Education$75.14 (1.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $5,389 320 98.6%
Education $75.14 3 1.4%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $1,174 86 $0 (2024)
Janssen Biotech, Inc. $817.62 40 $0 (2024)
Takeda Pharmaceuticals U.S.A., Inc. $774.46 46 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $645.44 40 $0 (2024)
Ardelyx, Inc. $274.83 9 $0 (2024)
Intercept Pharmaceuticals, Inc. $267.41 18 $0 (2024)
Gilead Sciences, Inc. $196.48 10 $0 (2022)
Celgene Corporation $191.51 11 $0 (2023)
QOL Medical, LLC $134.40 5 $0 (2024)
Regeneron Healthcare Solutions, Inc. $130.97 6 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,326 71 ABBVIE INC. ($265.86)
2023 $1,508 84 ABBVIE INC. ($276.87)
2022 $1,446 91 ABBVIE INC. ($343.13)
2021 $1,185 77 AbbVie Inc. ($288.34)

All Payment Transactions

323 individual payment records from CMS Open Payments — Page 1 of 13

Date Company Product Nature Form Amount Type
12/13/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $16.92 General
Category: GASTROENTEROLOGY
12/11/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $18.98 General
Category: Immunology
12/06/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $22.90 General
Category: INFLAMMATION AND IMMUNOLOGY
12/04/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $17.53 General
Category: INTERNAL MEDICINE
11/20/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $13.31 General
Category: LIVER DISEASE
11/15/2024 IRONWOOD PHARMACEUTICALS, INC Linzess (Drug) Food and Beverage Cash or cash equivalent $13.98 General
Category: GI
11/12/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $1.78 General
Category: IMMUNOLOGY
11/01/2024 Intercept Pharmaceuticals, Inc. OCALIVA (Drug) Food and Beverage In-kind items and services $14.60 General
Category: Hepatology / Gastroenterology
10/25/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $28.46 General
Category: INTERNAL MEDICINE
10/23/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $13.50 General
Category: IMMUNOLOGY
10/16/2024 QOL Medical, LLC SUCRAID (Drug) Food and Beverage Cash or cash equivalent $24.48 General
Category: THERAPY FOR CSID
10/11/2024 ABBVIE INC. LINZESS (Drug), CREON Food and Beverage In-kind items and services $15.56 General
Category: GASTROENTEROLOGY
10/09/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $22.41 General
Category: Immunology
10/08/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $34.96 General
Category: IMMUNOLOGY
10/08/2024 Takeda Pharmaceuticals U.S.A., Inc. EOHILIA (Drug) Food and Beverage In-kind items and services $17.19 General
Category: INTERNAL MEDICINE
10/04/2024 ABBVIE INC. SKYRIZI (Biological), RINVOQ Food and Beverage In-kind items and services $21.76 General
Category: IMMUNOLOGY
10/02/2024 Merck Sharp & Dohme LLC DIFICID (Drug), ZINPLAVA Food and Beverage In-kind items and services $13.97 General
Category: INFECTIOUS DISEASE
09/27/2024 Celltrion USA Inc. VEGZELMA (Biological) Food and Beverage In-kind items and services $16.89 General
Category: ONCOLOGY
09/25/2024 Takeda Pharmaceuticals U.S.A., Inc. ENTYVIO (Biological) Food and Beverage In-kind items and services $22.29 General
Category: INTERNAL MEDICINE
09/17/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $24.58 General
Category: Gastroenterology
09/13/2024 Madrigal Pharmaceuticals RESMETIROM (Drug) Food and Beverage In-kind items and services $13.85 General
Category: LIVER DISEASE
09/12/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC TRULANCE (Drug) Food and Beverage In-kind items and services $14.41 General
Category: Gastroenterology
09/04/2024 Ipsen Biopharmaceuticals, Inc IQIRVO (Drug) Food and Beverage In-kind items and services $19.48 General
Category: Rare Disease
08/28/2024 Alnylam Pharmaceuticals Inc. GIVLAARI (Drug) Food and Beverage In-kind items and services $18.08 General
Category: Genetic Disease
08/23/2024 AIMMUNE THERAPEUTICS, INC. ZENPEP (Drug) Food and Beverage In-kind items and services $18.82 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 5 440 539 $101,750 $33,357
2022 3 303 348 $63,910 $22,358
2021 2 267 315 $53,575 $18,131
2020 3 221 255 $34,975 $11,803
Total Patients
1,231
Total Services
1,457
Medicare Billing
$85,649
Procedure Codes
13

All Medicare Procedures & Services

13 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 231 291 $43,650 $15,123 34.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 121 160 $36,000 $11,563 32.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 55 55 $14,850 $5,070 34.1%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 20 20 $4,000 $1,351 33.8%
91200 Measurement of liver stiffness Office 2023 13 13 $3,250 $251.42 7.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 123 146 $32,850 $10,728 32.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 161 183 $25,975 $9,829 37.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 19 19 $5,085 $1,800 35.4%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 147 173 $21,625 $9,576 44.3%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 120 142 $31,950 $8,555 26.8%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 171 204 $25,500 $9,063 35.5%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 34 35 $7,875 $2,364 30.0%
99212 Established patient office or other outpatient visit, typically 10 minutes Office 2020 16 16 $1,600 $375.86 23.5%

About Jayda Rupp, APRN

Jayda Rupp, APRN is a Nurse Practitioner healthcare provider based in Topeka, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2015. The National Provider Identifier (NPI) number assigned to this provider is 1063892677.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jayda Rupp, APRN has received a total of $5,464 in payments from pharmaceutical and medical device companies, with $1,326 received in 2024. These payments were reported across 323 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($5,389).

As a Medicare-enrolled provider, Rupp has provided services to 1,231 Medicare beneficiaries, totaling 1,457 services with total Medicare billing of $85,649. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.

Practice Information

  • Specialty Nurse Practitioner
  • Location Topeka, KS
  • Active Since 06/09/2015
  • Last Updated 06/09/2015
  • Taxonomy Code 363L00000X
  • Entity Type Individual
  • NPI Number 1063892677

Products in Payments

  • ENTYVIO (Biological) $757.27
  • XIFAXAN (Drug) $528.19
  • REMICADE (Biological) $426.69
  • STELARA (Biological) $349.54
  • IBSRELA (Drug) $274.83
  • OCALIVA (Drug) $267.41
  • RINVOQ (Biological) $251.37
  • LINZESS (Drug) $221.30
  • SKYRIZI (Biological) $198.92
  • HUMIRA (Biological) $197.34
  • DUPIXENT (Biological) $196.89
  • MAVYRET (Drug) $195.03
  • ZEPOSIA (Drug) $191.51
  • DIFICID (Drug) $120.75
  • TRULANCE (Drug) $117.25
  • Linzess (Drug) $97.56
  • SUCRAID (Drug) $74.74
  • VIBERZI (Drug) $68.08
  • ZENPEP (Drug) $64.46
  • RENFLEXIS (Drug) $64.43

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nurse Practitioner Doctors in Topeka